Skip to main content
. 2022 Jan 21;6(2):600–610. doi: 10.1182/bloodadvances.2021005564

Figure 3.

Figure 3.

EM disease did not affect the loss of BCA. (A) The probability of BCA loss of patients with CNS3 disease, non-CNS EM disease, and BM-only disease (P = .14). (B) The probability of BCA loss of patients with active CNS disease (CNS+) at time of infusion compared with those with CNS disease that cleared (CNS) before infusion (P = .74). (C) The probability of BCA loss of patients with isolated CNS disease (iCNS) compared with those with combined CNS and BM disease (CNS + BM) (P = .71).